It has also been shown that lymph node metastasis in patients with gastric adenocarcinoma (35) and endometrial cancer (39), as well as liver metastasis in patients with colorectal cancer (155), can be partially attributed to IDO expression. Here, IDO1 is linked to endometrial cancer.